COMMUNIQUÉS West-GlobeNewswire

-
BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
03/06/2019 -
Annual General Meeting Results and Statement
03/06/2019 -
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness
03/06/2019 -
LHC Group announces finalization of purchase agreement and joint venture partnership in New Jersey
03/06/2019 -
RadNet, Inc. to Present at the Jefferies 2019 Healthcare Conference on June 7, 2019
03/06/2019 -
US FDA Review for SCENESSE® Extended by Three Months
03/06/2019 -
Arrayit Corporation Signs In-Network Allergy Testing Services Agreement with a Major California-Based Health Benefits Company
03/06/2019 -
Biohit Plc - Managers' transactions - Söderström
03/06/2019 -
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
03/06/2019 -
Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis
03/06/2019 -
New cigarette filters block up to 60% of harmful substances thanks to Bio-on biopolymers
03/06/2019 -
Grâce aux bio-polymères créés par Bio-on, les filtres de cigarettes sont en mesure de bloquer jusqu’à 60% des substances nocives
03/06/2019 -
Vical and Brickell Announce Merger Agreement
03/06/2019 -
DBV Technologies to Attend Upcoming Investor Conferences
03/06/2019 -
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
03/06/2019 -
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials
03/06/2019 -
Basilea reports publication of clinical data for anticancer drug candidates BAL101553 in glioblastoma and derazantinib in intrahepatic cholangiocarcinoma at ASCO meeting
03/06/2019 -
Xolair® (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies
03/06/2019 -
Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
03/06/2019
Pages